Eaton Vance Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,073
| Closed | -$65K | – | 2454 |
|
|
2021
Q4 | $65K | Buy |
1,073
+570
| +113% | +$34.5K | ﹤0.01% | 2001 |
|
|
2021
Q3 | $0 | Sell |
503
-263
| -34% | – | ﹤0.01% | 2505 |
|
|
2021
Q2 | $47K | Buy |
766
+388
| +103% | +$23.8K | ﹤0.01% | 2177 |
|
|
2021
Q1 | $26K | Buy |
+378
| New | +$26K | ﹤0.01% | 1983 |
|
|
2018
Q2 | – | Sell |
-271,106
| Closed | -$8.44M | – | 1186 |
|
|
2018
Q1 | $8.44M | Buy |
271,106
+65,970
| +32% | +$2.05M | 0.01% | 547 |
|
|
2017
Q4 | $9.36M | Hold |
205,136
| – | – | 0.02% | 397 |
|
|
2017
Q3 | $7.7M | Sell |
205,136
-204,065
| -50% | -$7.66M | 0.02% | 414 |
|
|
2017
Q2 | $19.5M | Buy |
+409,201
| New | +$19.5M | 0.05% | 262 |
|